Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007406:Interview, Psychological; D007902:Length of Stay; D008875:Middle Aged; D009788:Occupational Therapy; D010880:Piperidines / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy* / Q000628:therapy; D011795:Surveys and Questionnaires; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D010880:Piperidines; D010919:Placebos; D014149:Tranquilizing Agents